| Product Code: ETC12192373 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Latvia continued to heavily rely on imports of follicle-stimulating hormone, with top exporting countries being Metropolitan France, Germany, Lithuania, Poland, and the USA. The high Herfindahl-Hirschman Index (HHI) concentration indicates a limited number of suppliers dominating the market. Despite a strong compound annual growth rate (CAGR) of 43.42% from 2020 to 2024, there was a significant decline in growth rate from 2023 to 2024 at -57.01%. This shift may warrant further investigation into potential market fluctuations or regulatory changes impacting the import landscape for follicle-stimulating hormone in Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Follicle-Stimulating Hormone Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, 2022 & 2032F |
3.3 Latvia Follicle-Stimulating Hormone Market - Industry Life Cycle |
3.4 Latvia Follicle-Stimulating Hormone Market - Porter's Five Forces |
3.5 Latvia Follicle-Stimulating Hormone Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Latvia Follicle-Stimulating Hormone Market Revenues & Volume Share, By Form, 2022 & 2032F |
3.7 Latvia Follicle-Stimulating Hormone Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Latvia Follicle-Stimulating Hormone Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Latvia Follicle-Stimulating Hormone Market Revenues & Volume Share, By Dosage, 2022 & 2032F |
4 Latvia Follicle-Stimulating Hormone Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about infertility treatments and related hormonal therapies |
4.2.2 Growing prevalence of infertility issues among the population |
4.2.3 Technological advancements in fertility treatments and hormone therapy |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for hormone therapy products |
4.3.2 High cost associated with follicle-stimulating hormone treatments |
4.3.3 Limited availability of skilled healthcare professionals specializing in fertility treatments |
5 Latvia Follicle-Stimulating Hormone Market Trends |
6 Latvia Follicle-Stimulating Hormone Market, By Types |
6.1 Latvia Follicle-Stimulating Hormone Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Recombinant FSH, 2022 - 2032F |
6.1.4 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Urinary-Derived FSH, 2022 - 2032F |
6.1.5 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Human FSH, 2022 - 2032F |
6.1.6 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Synthetic FSH, 2022 - 2032F |
6.2 Latvia Follicle-Stimulating Hormone Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Injection, 2022 - 2032F |
6.2.3 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Powder, 2022 - 2032F |
6.2.4 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Liquid, 2022 - 2032F |
6.2.5 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Tablet, 2022 - 2032F |
6.3 Latvia Follicle-Stimulating Hormone Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Fertility Treatment, 2022 - 2032F |
6.3.3 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By IVF Procedures, 2022 - 2032F |
6.3.4 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Ovulation Induction, 2022 - 2032F |
6.3.5 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Hormone Replacement Therapy, 2022 - 2032F |
6.4 Latvia Follicle-Stimulating Hormone Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Fertility Clinics, 2022 - 2032F |
6.4.4 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Gynecology Centers, 2022 - 2032F |
6.4.5 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.5 Latvia Follicle-Stimulating Hormone Market, By Dosage |
6.5.1 Overview and Analysis |
6.5.2 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By 75 IU-150 IU, 2022 - 2032F |
6.5.3 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By 225 IU-450 IU, 2022 - 2032F |
6.5.4 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By 50 IU-100 IU, 2022 - 2032F |
6.5.5 Latvia Follicle-Stimulating Hormone Market Revenues & Volume, By 10 mg-50 mg, 2022 - 2032F |
7 Latvia Follicle-Stimulating Hormone Market Import-Export Trade Statistics |
7.1 Latvia Follicle-Stimulating Hormone Market Export to Major Countries |
7.2 Latvia Follicle-Stimulating Hormone Market Imports from Major Countries |
8 Latvia Follicle-Stimulating Hormone Market Key Performance Indicators |
8.1 Number of fertility clinics offering follicle-stimulating hormone treatments in Latvia |
8.2 Adoption rate of advanced fertility treatments involving follicle-stimulating hormone |
8.3 Patient satisfaction rates with follicle-stimulating hormone therapy services |
9 Latvia Follicle-Stimulating Hormone Market - Opportunity Assessment |
9.1 Latvia Follicle-Stimulating Hormone Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Latvia Follicle-Stimulating Hormone Market Opportunity Assessment, By Form, 2022 & 2032F |
9.3 Latvia Follicle-Stimulating Hormone Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Latvia Follicle-Stimulating Hormone Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Latvia Follicle-Stimulating Hormone Market Opportunity Assessment, By Dosage, 2022 & 2032F |
10 Latvia Follicle-Stimulating Hormone Market - Competitive Landscape |
10.1 Latvia Follicle-Stimulating Hormone Market Revenue Share, By Companies, 2025 |
10.2 Latvia Follicle-Stimulating Hormone Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here